Loading the session
Loading the session
Loading instrument
$20.00
+2.25%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 05:12 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 close of $20.17 was 1.9% above its 50-day average ($19.79) and 5.3% above its 200-day average ($19.16). It has closed above the 200-day for 3 sessions, since 2 Nov 2026. The 50-day average crossed above the 200-day on 27 May 2026, 112 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
$0.1017 a share, payable 25 Nov 2026; unchanged from the previous payment (ex-date 19 Oct 2026).
Corporate actions record · as of 5 Nov 2026
1 month: +6.2% (SPY −1.6%, XLRE +9.8%). 3 months: −7.4% (SPY −0.4%, XLRE −0.2%). 1 year: +15.0% (SPY +13.6%, XLRE +10.2%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: DOC, SPY and XLRE · as of 4 Nov 2026
Closed at $20.17 on 4 Nov 2026: 12.1% below the 52-week high of $22.95 (28 Jul 2026) and 28.5% above the low of $15.70 (28 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
21.7M shares were sold short at the 15 Oct 2026 settlement, 3.2% of the 689.5M shares outstanding; covering them would take 3.5 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.
May 6, 2026
+18.11%March 4, 2024
+50.04%November 14, 2023
+8.57%